Skip to content

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03906383
Enrollment
21
Registered
2019-04-08
Start date
2017-11-21
Completion date
2018-10-16
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Complications, Diabetes Mellitus, Type 1, Ischemia, Retinal Ischemia

Brief summary

Remote ischemic conditioning (RIC) is a therapeutic strategy for protecting organs or tissue against the detrimental effects of acute ischemia-reperfusion injury. It remains unknown whether this can be used in retinal ischemic diseases. The purpose of the present study is to examine if the autoregulation of retinal vessel diameters in diabetic patients change after remote ischemic conditioning and if the observations are different from what have been observed in normal persons.

Interventions

OTHERRemote Ischemic Conditioning

Brief reversible restriction of blood flow to upper limb in four cycles of 5 minutes of inflation at 200mm Hg followed by 5 minutes of deflation.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 31 Years
Healthy volunteers
No

Inclusion criteria

* Diabetes type 1 * Diabetic retinopathy

Exclusion criteria

* Previous treatment for diabetic retinopathy * Other ocular and systemic diseases requiring treatment * Pregnancy or lactation

Design outcomes

Primary

MeasureTime frameDescription
Diameter change of retinal vesselsImmediately after and one hour afterDiameter change from baseline in percent.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026